桂皮醛衍生物的合成及其对CVB3的作用

目的:合成桂皮醛衍生物,观测其对心肌细胞的毒性及抗CVB3病毒的作用.方法:化学合成6种桂皮醛衍生物,其中3种进行了红外、质谱等结构表征;MTT法检测被CVB3病毒感染和用桂皮醛衍生物治疗后的心肌细胞活性.结果:α-溴代对氨肉桂醛、α-溴代对甲基肉桂醛、对氯肉桂醛3种桂皮醛衍生物对心肌细胞的半教毒性浓度(TC50)分别为2151.28μ g·mL-1,1475.32μg·mL-1,22460.32μ g·mL-1;对CVB3病毒的半数抑制浓度(IC50)分别为178.94μg·mL-1、173.35μg·mL-1,6045.25μg·mL-1;对CVB3病毒的治疗指数(TI)分别为12.02,8.51,3.71.结论:桂皮醛3种衍生物具有直接抑制CVB3病毒作用,但对病毒的细胞合成和吸附无明显作用.     

桂皮醛对小鼠柯萨奇病毒诱发病毒性心肌炎的作用(英文)

已知Toll样受体4(Toll-like receptors 4,TLR4)及其下游信号组分在柯萨奇病毒(CoxsackievirusB,CVB)诱发的病毒性心肌炎中扮演重要的角色,其在治疗中的作用仍不明确。桂皮醛具有抗病毒以及成剂量依赖性抑制由TLR4诱导的核因子活性的作用,而其对病毒性心肌炎的作用机制尚不明确。我们的实验结果显示:在体外,桂皮醛对正常心肌细胞的IC50为15μM;100-1000μM桂皮醛能显著抑制心肌细胞中的病毒滴度(P0.01),而细胞存活率与CVB组无统计学差异(P0.01)。而在病毒性心肌炎小鼠体内,与模型组比较,20和40mg/kg桂皮醛i.p.使第7 d血清中NO的含量以及心肌中诱导型一氧化氮合酶(inducible nitric oxide synthase,iNOS),肿瘤坏死因子(tumor necrosis factor,TNF-α),核因子κB P65(nuclear factor-κB P65,NF-κB P65)和TLR4蛋白质表达显著降低(P0.05)。降低第21 d心脏体重比(Heat Weight/Body Weight,Hw/Bw)比值,提高小鼠生存率,减轻病理损伤的作用。这些结果显示桂皮醛虽在体外无抗病毒活性,但其在体内具有降低病毒滴度和抑制TLR-4-NF-κB信号传导的作用,对病毒性心肌炎小鼠具有治疗作用。桂皮醛可能通过对TLR-4-NF-κB信号传导抑制作用,作为一种新的方法治疗病毒性心肌炎。     

含硫香料——硫代芳樟醇及其衍生物的合成研究

本文对香叶醇转化为硫代芳樟醇(4)及其衍生物的合成方法进行了研究。香叶醇与N,N-二甲基琉代氨基甲酰氯反应生成N,N—二甲基琉代氨基甲酸-O-香叶基酯(5),(5)通过[3,3]-σ迁移反应转变成N,N-二甲基硫代氨基甲酸-S-芳樟基酯(6),(6)进一步还原得到硫代芳樟醇(4)。(4)转变成衍生物硫代芳樟醇乙酸酯(7a)及芳樟基甲基疏醚(7b)。(4)及(7b)在高度稀释时具有愉快的热带水果香味。     

弗赖森草螺菌RE3-3合成生长素及其促生作用的研究

研究弗赖森草螺菌RE3-3菌株的培养条件对其生长素(IAA)生物合成的影响,并观察菌株合成IAA对芦苇及香蒲幼苗的促生影响。在单因素筛选和菌液初始浓度确定的基础上,对菌株RE3-3合成IAA的培养条件进行优化;以IAA标准物质为对照,对菌株合成IAA促进芦苇及香蒲苗的生长能力进行分析。通过高效液相色谱与质谱分析鉴定其产物为IAA;培养基中含0.07%L-色氨酸及1%葡萄糖,在p H 7.0、温度30℃、培养时间48 h的最佳培养条件下,菌株RE3-3可产生最大量的IAA(74 mg/L);菌株合成IAA作用芦苇及香蒲苗时,其促生效果最显著,植株根长、茎长明显提高。通过改变菌株RE3-3的培养条件,可提高其合成IAA的能力,且菌株RE3-3合成IAA具有显著的促生效果。     

药物对病毒感染培养心肌细胞Ca~（2＋）内流及CVB_3－RNA复制的影响

应用放射性同位素￣（４５）Ｃａ￣（２＋）示踪技术及光敏生物素标记ｃＤＮＡ探针杂交方法,观察了维拉帕米、黄芪、地塞米松等药物对感染柯萨奇Ｂ＿３病毒（ＣＶＢ＿３）的大鼠培养心肌细胞Ｃａ￣（２＋）内流及细胞中ＣＶＢ＿３－ＲＮＡ复制的作用。结果发现：在病毒感染４８ｈ,上述三药均可显著减少感染细胞及正常对照的心肌Ｃａ￣（２＋）内流（Ｐ＜０．０１和Ｐ＜０．０５）;若在病毒感染后即加入上述药物,经４８ｈ培养后,黄芪组细胞中的ＣＶＢ＿３－ＲＮＡ含量显著少于病毒对照组（Ｐ＜０．００１）,维拉帕米则显著增加（Ｐ＜０．０１）．而地塞米松对其无影响。提示黄芪与地塞米松具有一种与维拉帕米相似的减少病毒感染心肌Ｃａ￣（２＋）内流的作用,有可能减轻感染细胞的继发性Ｃａ￣（２＋）损伤;但三种药物对感染细胞中病毒核酸的复制有不同作用,可作为临床治疗病毒性心肌炎时的参考。     

对-氯代苯胺(PCA)在填充床生物反应器中的降解作用

以氯代苯胺(PCA)为选择基质,用驯化技术从降解对二氯苯(p-DCB)的富集培养物中得到了以同化PCA为唯一碳源和氮源的混合微生物。将这种固定在填充床反应器中的微生物用于PCA的降解作用研究中。在该反应器里,PCA的生物降解遵循Logistic方程q=q_max/(1+e^α-βU_v).由方程求出了主要的动力学常数,K_s(半速率常数)和q_max(最大比基质降解速率).于PCA降解的同时,释放氯离子到培养基中。在水力停留时间3h, 进水PCA浓度为360mg·L^-1情况下,基质的体积降解率达到125mg·L^-1·h^-1;基质的百分去除率为91%.     

对—氯代苯胺（PCA）在填充床生物反应器中的降解作用

以氯代苯胺（ＰＣＡ）为选择基质,用驯化技术从降解对二氯苯（ｐＤＣＢ）的富集培养物中得到了以同化ＰＣＡ为唯一碳源和氮源的混合微生物．将这种固定在填充床反应器中的微生物用于ＰＣＡ的降解作用研究中．在该反应器里,ＰＣＡ的生物降解遵循Ｌｏｇｉｓｔｉｃ方程ｑ＝ｑｍａｘ／（１＋ｅα－βＵｖ）．由方程求出了主要的动力学常数,Ｋｓ（半速率常数）和ｑｍａｘ（最大比基质降解速率）．于ＰＣＡ降解的同时,释放氯离子到培养基中．在水力停留时间３ｈ,进水ＰＣＡ浓度为３６０ｍｇ·Ｌ－１情况下,基质的体积降解率达到１２５ｍｇ·Ｌ－１·ｈ－１;基质的百分去除率为９１％．     

紫外灭活CVB3 病毒诱导BALB/c小鼠产生免疫保护作用的研究

目的:探讨紫外灭活型CVB3病毒诱导BALB/c小鼠产生特异性免疫应答及保护作用的评估。方法:采用紫外灭活的方法处理野生型CVB3m株,按照0.1 LD50(10~4 PFU)的剂量免疫小鼠,设置PBS免疫组作为对照,免疫后第3,5,7天收集小鼠血清,检测细胞因子含量;在第3,5,7,14天分离小鼠脾脏,流式分析T细胞亚群的分布比例;在免疫后一个月分离小鼠血清,检测中和抗体的滴度;同时间给予小鼠100LD 50野生型CVB3感染,观察小鼠的死亡率。结果:与对照组相比,在检测日期内紫外灭活型CVB3组小鼠血清中细胞因子IL-1α,TNF-α,IL-6的表达量明显增高(P0.05),IL-4的表达量没有明显差异;免疫后第14天CD3~+CD4~+T细胞的分布较对照组明显升高(P0.05);在免疫后一个月,紫外灭活型CVB3免疫组可以诱导机体产生高滴度中和抗体,同时,小鼠应对高致死量CVB3感染时有较高的存活率。结论:紫外灭活型CVB3感染能诱导机体产生特异性免疫应答,同时,产生的中和抗体可以提高小鼠应对致死剂量CVB3感染时的生存率,对机体有明显的保护作用。     

离子液体1-丁基-3-甲基咪唑氯代盐对溶菌酶结晶的影响

以亲水性离子液体1-丁基-3-甲基咪唑氯盐(BmimCl)为添加剂,研究离子液体对溶菌酶结晶的影响.分别考察了离子液体对溶菌酶晶体数量与尺寸、晶体形貌及蛋白质纯度的影响,并探讨了离子液体对结晶过程影响的作用机制.离子液体通过增大溶菌酶的溶解度和其自身低蒸气压两种途径,降低了溶菌酶在结晶过程中的过饱和度,更有利于晶体的成核和生长,得到更好的结果.如避免多晶态现象的发生,增大晶体的尺寸,降低溶菌酶样品纯度的要求.X-射线衍射分析表明,离子液体未改变晶体的晶型结构,但可提高晶体的衍射分辨率.     

熊果酸衍生物的合成及其对肺癌细胞活性抑制的研究

目的：探讨合成的熊果酸衍生物对肺癌LTEP-α-2肿瘤细胞增殖的抑制作用。方法：熊果酸经氧化、肟化和腙化合成为3-氧代熊果酸、3-肟基熊果酸和3-（2＇,4＇-二硝基）-苯腙熊果酸。采用MTT法检测熊果酸及其衍生物对肺癌LTEP-α-2细胞的体外抗肿瘤活性。结果：熊果酸及其衍生物对肺癌LTEP-α-2细胞有抑制作用,且3-肟基熊果酸对肺癌LTEP-α-2细胞抑制作用高于其他化合物,其抑制率为90.0%,IC50为7.4μg/m L。结论：熊果酸衍生物3-肟基熊果酸抗肺癌LTEP-α-2肿瘤细胞活性高于熊果酸的活性。     

Synthesis and antitumor activity of cholest-4 alpha-methyl-7-en-3beta-ol derivatives

Cholest-4 alpha-methyl-7-en-3beta-ol (1) has potent inhibitory activity against pc 12 tumor with 0.5043 ratio (10 microg/mL). This paper describes a series of structural modification of this compound, which focus on 3beta-hydroxyl group and 7(8)-double bond. The synthesized derivatives of 1 were tested for human cancer cell lines including colon cancer (HCT-8), liver cancer (BEL-7402) and nasopharyngeal cancer (KB) cells. The results showed that cholest-4 alpha-methyl-8-en-3beta,7 alpha-diol 6a inhibits KB cell significantly with IC(50) 1.32 x 10(-9)microg/mL. In addition, the cytotoxic properties of this compound against HCT-8 and BEL-7402 are excellent with IC(50) 1.2 microg/mL.     

Synthesis and biological evaluation of 4-oxoquinoline-3-carboxamides derivatives as potent anti-fibrosis agents

Thirty-one 4-oxoquinoline-3-carboxamides derivatives were synthesized and evaluated for their anti-fibrotic activities by the inhibition of TGF-β1-induced total collagen accumulation and anti-inflammatory activities by the inhibition of LPS-stimulated TNF-α production. Among them, three compounds (10a, 10l and 11g) exhibited potent inhibitory effects on both TGF-β1-induced total collagen accumulation and LPS-stimulated TNF-α production. Furthermore, oral administrations of 10l at a dose of 20 mg/kg/day for 4 weeks effectively alleviated lung inflammation and injury, and decreased lung collagen accumulation in bleomycin-induced pulmonary fibrosis model. Histopathological evaluation of lung tissue confirmed 10l as a potential, orally active agent for the treatment of pulmonary fibrosis.     

Synthesis and biological evaluation of 3-arylcoumarin derivatives as potential anti-diabetic agents

A variety of substituted 3-arylcoumarin derivatives were synthesised through microwave radiation heating. The method has characteristics of environmental friendliness, economy, simple separation, and purification process, less by-products and high reaction yield. Those 3-arylcoumarin derivatives were screened for antioxidant, α-glucosidase inhibitory and advanced glycation end-products (AGEs) formation inhibitory. Most compounds exhibited significant antioxidant and AGEs formation inhibitory activities. Anti-diabetic activity studies showed that compounds 11 and 17 were equipotent to the standard drug glibenclamide in vivo. According to the experimental results, the target compound 35 can be used as a lead compound for the development of new anti-diabetic drugs. The whole experiment showed that anti-diabetic activity is prevalent in 3-arylcoumarins, which added a new natural skeleton to the development of anti-diabetic active drugs.     

Synthesis of 3-methyl-3-hydroxy-6-oxo-androstane derivatives

3alpha,17beta-Dihydroxy-3beta-methyl-5alpha-androstan-6-one (1) and 3beta,17beta-dihydroxy-3alpha-methyl-5alpha-androstan-6-one (13) were prepared by the reaction of methylmagnesium bromide with the 3-ketosteroids. Structures and configurations in position 3 were determined by NMR spectra. Substitution in the position 6 influences the ratio of the products.     

Synthesis and anti-rheumatoid arthritis activities of 3-(4-aminophenyl)-coumarin derivatives

Rheumatoid arthritis is a chronic systemic disease characterised by an unknown aetiology of inflammatory synovitis. A large number of studies have shown that synoviocytes show tumour-like dysplasia in the pathological process of RA, and the changes in the expression of related cytokines are closely related to the pathogenesis of RA. In this thesis, a series of novel 3-(4-aminophenyl) coumarins containing different substituents were synthesised to find new coumarin anti-inflammatory drugs for the treatment of rheumatoid arthritis. The results of preliminary activity screening showed that compound 5e had the strongest inhibitory activity on the proliferation of fibroid synovial cells, and it also had inhibitory effect on RA-related cytokines IL-1, IL-6, and TNF-α. The preliminary mechanism study showed that compound 5e could inhibit the activation of NF-κB and MAPKs signal pathway. The anti-inflammatory activity of compound 5e in vivo was further determined in the rat joint inflammation model.     

Baker’s yeast mediated asymmetric reduction of cinnamaldehyde derivatives

The enantioselective reduction of cinnamaldehyde derivatives is an attractive strategy to prepare various optically active multifunctional molecules that can be used as chiral building blocks for the synthesis of some HIV-protease inhibitors. The asymmetric reduction with pH adjusted to 5.5 of α-substituted-cinnamaldehydes (Br, N₃) mediated by baker’s yeast (Saccharomyces cerevisiae) yielded α-substituted-3-phenyl-1-propanol in excellent enantiomeric excesses and yields.     

The nonstructural protein 2C of Coxsackie B virus has RNA helicase and chaperoning activities

RNA-remodeling proteins, including RNA helicases and chaperones, play vital roles in the remodeling of structured RNAs. During viral replication, viruses require RNA-remodeling proteins to facilitate proper folding and/or re-folding the viral RNA elements. Coxsackieviruses B3 (CVB3) and Coxsackieviruses B5 (CVB5), belonging to the genus Enterovirus in the family Picornaviridae, have been reported to cause various infectious diseases such as hand-foot-and-mouth disease, aseptic meningitis, and viral myocarditis. However, little is known about whether CVB3 and CVB5 encode any RNA remodeling proteins. In this study, we showed that 2C proteins of CVB3 and CVB5 contained the conserved SF3 helicase A, B, and C motifs, and functioned not only as RNA helicase that unwound RNA helix bidirectionally in an NTP-dependent manner, but also as RNA chaperone that remodeled structured RNAs and facilitated RNA strand annealing independently of NTP. In addition, we determined that the NTPase activity and RNA helicase activity of 2C proteins of CVB3 and CVB5 were dependent on the presence of divalent metallic ions. Our findings demonstrate that 2C proteins of CVBs possess RNA-remodeling activity and underline the functional importance of 2C protein in the life cycle of CVBs.     

Synthesis and radioprotective effects of novel hybrid compounds containing edaravone analogue and 3-n-butylphthalide ring-opening derivatives

As the potential risk of radiation exposure is increasing, radioprotectors studies are gaining importance. In this study, novel hybrid compounds containing edaravone analogue and 3-n-butylphthalide ring-opening derivatives were synthesized, and their radioprotective effects were evaluated. Among these, compound 10a displayed the highest radioprotective activity in IEC-6 and HFL-1 cells. Its oral administration increased the survival rates of irradiated mice and alleviated total body irradiation (TBI)-induced hematopoietic damage by mitigating myelosuppression and improving hematopoietic stem/progenitor cell frequencies. Furthermore, 10a treatment prevented abdominal irradiation (ABI)-induced structural damage to the small intestine. Experiment results demonstrated that 10a increased the number of Lgr5⁺ intestinal stem cells, lysozyme⁺ Paneth cells and Ki67⁺ transient amplifying cells, and reduced apoptosis of the intestinal epithelium cells in irradiated mice. Moreover, in vitro and in vivo studies demonstrated that the radioprotective activity of 10a is associated to the reduction of oxidative stress and the inhibition of DNA damage. Furthermore, compound 10a downregulated the expressions of p53, Bax, caspase-9 and caspase-3, and upregulated the expression of Bcl-2, suggesting that it could prevent irradiation-induced intestinal damage through the p53-dependent apoptotic pathway. Collectively, these findings demonstrate that 10a is beneficial for the prevention of radiation damage and has the potential to be a radioprotector.